CRWV Insider Sale Notice: 157,903 Shares via Morgan Stanley

Rhea-AI Filing Summary

Form 144 notice for CoreWeave, Inc. (CRWV) reports a proposed sale of 157,903 common shares through Morgan Stanley Smith Barney, with an aggregate market value of $19,346,275.56, from a total of 370,470,348 shares outstanding. The approximate date of sale is 09/30/2025. The filing shows the securities to be sold consist of 100,000 founders shares acquired 11/13/2017 and 57,903 restricted stock units granted as compensation on 09/30/2025.

The notice also discloses a series of Rule 10b5-1 sales by Brannin McBee and the Brannin J. McBee 2022 IRR Trust during August and September 2025; the filing lists 12 separate 10b5-1 sale entries with individual gross proceeds shown for each trade. The filer certifies no undisclosed material adverse information and references compliance with Rule 144 and any applicable 10b5-1 plan.

Positive

• Transparent disclosure of the proposed sale amount (157,903 shares) and aggregate market value ($19,346,275.56)
• Breakout of acquisition types provided: 100,000 founders shares (11/13/2017) and 57,903 RSUs (09/30/2025)
• Broker identified for the transaction: Morgan Stanley Smith Barney, indicating an institutional execution channel
• Historical 10b5-1 trades listed (12 entries), providing visibility into recent insider selling activity

Negative

• Substantial insider selling activity shown by multiple 10b5-1 transactions in Aug–Sep 2025, including individual gross proceeds up to $49,435,537.50
• Filing presents insider liquidity which investors may interpret unfavorably despite being routine and pre-planned

Insights

Securities Analyst

TL;DR: Routine insider sale notice showing planned sale of 157,903 shares and multiple recent 10b5-1 transactions; material as a disclosure but not a financial-performance event.

The Form 144 is a standard disclosure of an intended sale by an insider or related account rather than a company operational update. Key items are the number of shares proposed for sale (157,903), the broker (Morgan Stanley Smith Barney), and the split between founders shares and recently issued restricted stock units. The inclusion of 12 recent 10b5-1 sales with explicit gross proceeds provides transparency on prior dispositions. For investors this is a governance and liquidity signal rather than an earnings or credit event; it documents insider selling activity but does not in itself indicate company performance.

Corporate Governance Expert

TL;DR: Filing demonstrates compliance with disclosure rules and use of 10b5-1 plans; notable for frequency and magnitude of prior insider sales.

This submission meets Rule 144 disclosure requirements by identifying the class, amount, acquisition dates, and nature of acquisition (founders shares and RSUs). The presence of multiple 10b5-1 sale records in August–September 2025 indicates pre-arranged trading plans were executed, which supports procedural compliance. The statement that the signer is unaware of undisclosed material adverse information is included as required. From a governance perspective, the document is routine but worth monitoring due to numerous recent insider dispositions reflected in the filing.

Form 144 Filer Information	UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 144 NOTICE OF PROPOSED SALE OF SECURITIES PURSUANT TO RULE 144 UNDER THE SECURITIES ACT OF 1933
FORM 144

144: Filer Information

Filer CIK
Filer CCC
Is this a LIVE or TEST Filing?	LIVE TEST
Submission Contact Information
Name
Phone
E-Mail Address

144: Issuer Information

Name of Issuer

SEC File Number

Address of Issuer

Phone

Name of Person for Whose Account the Securities are To Be Sold

See the definition of "person" in paragraph (a) of Rule 144. Information is to be given not only as to the person for whose account the securities are to be sold but also as to all other persons included in that definition. In addition, information shall be given as to sales by all persons whose sales are required by paragraph (e) of Rule 144 to be aggregated with sales for the account of the person filing this notice.

Relationship to Issuer

144: Securities Information

Title of the Class of Securities To Be Sold	Name and Address of the Broker	Number of Shares or Other Units To Be Sold	Aggregate Market Value	Number of Shares or Other Units Outstanding	Approximate Date of Sale	Name the Securities Exchange
Common	Morgan Stanley Smith Barney LLC Executive Financial Services 1 New York Plaza 8th Floor New York NY 10004	157903	19346275.56	370470348	09/30/2025	NASDAQ

Furnish the following information with respect to the acquisition of the securities to be sold and with respect to the payment of all or any part of the purchase price or other consideration therefor:

144: Securities To Be Sold

Title of the Class	Date you Acquired	Nature of Acquisition Transaction	Name of Person from Whom Acquired	Is this a Gift?	Date Donor Acquired	Amount of Securities Acquired	Date of Payment	Nature of Payment *
Common	11/13/2017	Founders Shares	Issuer			100000	11/13/2017	N/A
Common	09/30/2025	Acquired as compensation -- Restricted Stock Units	Issuer			57903	09/30/2025	Compensation

* If the securities were purchased and full payment therefor was not made in cash at the time of purchase, explain in the table or in a note thereto the nature of the consideration given. If the consideration consisted of any note or other obligation, or if payment was made in installments describe the arrangement and state when the note or other obligation was discharged in full or the last installment paid.

Furnish the following information as to all securities of the issuer sold during the past 3 months by the person for whose account the securities are to be sold.

144: Securities Sold During The Past 3 Months

Name and Address of Seller	Title of Securities Sold	Date of Sale	Amount of Securities Sold	Gross Proceeds
10b5-1 Sales for BRANNIN MCBEE 290 W Mt. Pleasant Ave. Suite 4100 Livingston NJ 07039	Common	09/23/2025	250000	32957025.00
10b5-1 Sales for BRANNIN J. MCBEE 2022 IRR TRUST 290 W Mt. Pleasant Ave. Suite 4100 Livingston NJ 07039	Common	09/23/2025	375000	49435537.50
10b5-1 Sales for BRANNIN MCBEE 290 W Mt. Pleasant Ave. Suite 4100 Livingston NJ 07039	Common	09/16/2025	250000	29542575.00
10b5-1 Sales for BRANNIN J. MCBEE 2022 IRR TRUST 290 W Mt. Pleasant Ave. Suite 4100 Livingston NJ 07039	Common	09/16/2025	375000	44313862.50
10b5-1 Sales for BRANNIN MCBEE 290 W Mt. Pleasant Ave. Suite 4100 Livingston NJ 07039	Common	09/09/2025	250000	24866825.00
10b5-1 Sales for BRANNIN J. MCBEE 2022 IRR TRUST 290 W Mt. Pleasant Ave. Suite 4100 Livingston NJ 07039	Common	09/09/2025	375000	37301250.00
10b5-1 Sales for BRANNIN MCBEE 290 W Mt. Pleasant Ave. Suite 4100 Livingston NJ 07039	Common	09/02/2025	250000	23292325.00
10b5-1 Sales for BRANNIN J. MCBEE 2022 IRR TRUST 290 W Mt. Pleasant Ave. Suite 4100 Livingston NJ 07039	Common	09/02/2025	375000	34938487.50
10b5-1 Sales for BRANNIN MCBEE 290 W Mt. Pleasant Ave. Suite 4100 Livingston NJ 07039	Common	08/26/2025	250000	22996925.00
10b5-1 Sales for BRANNIN J. MCBEE 2022 IRR TRUST 290 W Mt. Pleasant Ave. Suite 4100 Livingston NJ 07039	Common	08/26/2025	375000	34495387.50
10b5-1 Sales for BRANNIN MCBEE 290 W Mt. Pleasant Ave. Suite 4100 Livingston NJ 07039	Common	08/19/2025	250000	22926475.00
10b5-1 Sales for BRANNIN J. MCBEE 2022 IRR TRUST 290 W Mt. Pleasant Ave. Suite 4100 Livingston NJ 07039	Common	08/19/2025	375000	34389712.50

144: Remarks and Signature

Remarks

Date of Notice

Date of Plan Adoption or Giving of Instruction, If Relying on Rule 10b5-1

ATTENTION:

The person for whose account the securities to which this notice relates are to be sold hereby represents by signing this notice that he does not know any material adverse information in regard to the current and prospective operations of the Issuer of the securities to be sold which has not been publicly disclosed. If such person has adopted a written trading plan or given trading instructions to satisfy Rule 10b5-1 under the Exchange Act, by signing the form and indicating the date that the plan was adopted or the instruction given, that person makes such representation as of the plan adoption or instruction date.

Signature

ATTENTION: Intentional misstatements or omission of facts constitute Federal Criminal Violations (See 18 U.S.C. 1001)

FAQ

What shares does the Form 144 for CRWV propose to sell?

The filing proposes sale of 157,903 common shares through Morgan Stanley Smith Barney, with an aggregate market value of $19,346,275.56.

When is the approximate sale date listed on the Form 144?

The approximate date of sale is listed as 09/30/2025.

What is the composition of the shares being sold according to the filing?

The securities to be sold include 100,000 founders shares acquired 11/13/2017 and 57,903 restricted stock units granted as compensation on 09/30/2025.

Does the filing show prior insider sales?

Yes; the filing lists 12 Rule 10b5-1 sales by Brannin McBee and the Brannin J. McBee 2022 IRR Trust during August and September 2025, with individual gross proceeds shown for each trade.

Who is the broker handling the proposed sale?

The broker named is Morgan Stanley Smith Barney LLC, Executive Financial Services at 1 New York Plaza, New York, NY.